Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hound Partners is a New York-based investment management firm founded in 2004 by Jonathan Auerbach. Originally seeded by Julian Robertson of Tiger Management, the firm is recognized as a 'Tiger Seed' and follows a fundamental long/short equity investment strategy. While the firm is a generalist investor, it maintains a significant and active presence in the healthcare, biopharmaceutical, and medical technology sectors through its equity holdings. Hound Partners is known for its concentrated portfolio and rigorous, research-intensive approach to identifying high-conviction investment opportunities across various industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hound Partners.